The involvement of p53 signaling pathway was previously reported in human lung samples of SSc-ILD and IPF, but not fHP and other CTD-ILDs [10, 36, 37], and its activation was proven to promote lung fibrosis resolution in aged mice [38], which is also reflected in our research. The gene discussed is TP53; the disease is systemic sclerosis.